Summary & Overview
HCPCS J7295: Ethinyl Estradiol/Etonogestrel Monthly Vaginal Ring
HCPCS Level II code J7295 covers the monthly vaginal contraceptive ring containing ethinyl estradiol 0.015 mg and etonogestrel 0.12 mg per 24 hours, billed per unit. This code matters nationally as it standardizes billing for a commonly used long-acting, user-controlled hormonal contraceptive method, affecting coverage decisions, pharmacy benefit management, and family planning access across payers. Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents and where the service is typically provided, along with what to expect from payer coverage and billing practice discussions. The publication provides benchmarks for utilization and reimbursement patterns, notes relevant policy updates affecting contraceptive coverage, and summarizes clinical context for the device’s use. Practical implications for billing teams, revenue cycle managers, and policy analysts are presented without prescribing clinical actions. Data not available in the input is noted when applicable.
Billing Code Overview
HCPCS Level II code J7295 represents a monthly vaginal contraceptive ring delivering ethinyl estradiol 0.015 mg and etonogestrel 0.12 mg per 24 hours, supplied as each unit. The service type is contraceptive drug/device administration (provision of a monthly vaginal ring). The typical site of service is outpatient ambulatory care settings, including family planning clinics, gynecology offices, and other outpatient clinics where contraceptive devices are dispensed or provisioned.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 28-year-old woman presents to a gynecology clinic requesting a reversible, long-acting contraceptive option. She has regular menses, no contraindications to combined hormonal contraception, and desires monthly replacement of a vaginal ring. The clinician confirms eligibility through medical history, blood pressure measurement, and screening for risk factors (smoking, migraine with aura, thromboembolic disease). After shared decision-making, the clinician provides counseling on insertion, removal, expected bleeding patterns, and adverse effects. The clinic stock dispenses the product coded as J7295 for administration and patient self-use. Typical workflow includes verification of prescription, documentation of informed consent and counseling, vitals and relevant history, dispensing or device provision, and scheduling a follow-up or refill. Typical site of service is an outpatient ambulatory clinic or specialty gynecology practice where clinicians provide contraceptive counseling and device provision. For some patients, primary care or family planning clinics also provide this service. Emergency, inpatient, and facility-based operating room settings are not typical for routine provision of this monthly vaginal ring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when additional work or resources were required for counseling, device education, or complex dispensing beyond the usual service. |